Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays

Firefly luciferase-based reporter gene assays are the most commonly used assays to investigate the transcriptional regulation of gene expression. However, direct interaction of tested compounds with the firefly luciferase leading to altered enzymatic activity may lead to misinterpretation of experim...

Full description

Saved in:
Bibliographic Details
Main Authors: Becker, Jonas Philipp (Author) , Clemens, Jannick (Author) , Theile, Dirk (Author) , Weiß, Johanna (Author)
Format: Article (Journal)
Language:English
Published: 17 June 2016
In: Analytical biochemistry
Year: 2016, Volume: 509, Issue: Supplement C, Pages: 124-129
ISSN:1096-0309
DOI:10.1016/j.ab.2016.06.015
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ab.2016.06.015
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0003269716301427
Get full text
Author Notes:Jonas Philipp Becker, Jannick Robert Clemens, Dirk Theile, Johanna Weiss

MARC

LEADER 00000caa a2200000 c 4500
001 1566741424
003 DE-627
005 20220814051610.0
007 cr uuu---uuuuu
008 171222s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ab.2016.06.015  |2 doi 
035 |a (DE-627)1566741424 
035 |a (DE-576)49674142X 
035 |a (DE-599)BSZ49674142X 
035 |a (OCoLC)1340985573 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Becker, Jonas Philipp  |d 1991-  |e VerfasserIn  |0 (DE-588)1050230825  |0 (DE-627)783666160  |0 (DE-576)404441149  |4 aut 
245 1 0 |a Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays  |c Jonas Philipp Becker, Jannick Robert Clemens, Dirk Theile, Johanna Weiss 
264 1 |c 17 June 2016 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.12.2017 
520 |a Firefly luciferase-based reporter gene assays are the most commonly used assays to investigate the transcriptional regulation of gene expression. However, direct interaction of tested compounds with the firefly luciferase leading to altered enzymatic activity may lead to misinterpretation of experimental data. When investigating the proteasome inhibitors bortezomib, carfilzomib, and ixazomib, we observed increased luminescence for bortezomib and ixazomib, but not for carfilzomib, in a pregnane-X-receptor (PXR) reporter gene assay, which was inconsistent with the mRNA expression levels of the main PXR target gene CYP3A4. To further scrutinize this phenomenon, we performed experiments with constitutively expressed firefly luciferase and demonstrated that the increase in cellular firefly luciferase activity is independent from PXR activation or CYP3A4 promoter. Using cell-free assays with recombinant firefly luciferase enzyme, we made the counterintuitive observation that firefly luciferase activity is inhibited by bortezomib and ixazomib in a reversible and competitive manner. This inhibition stabilizes the firefly luciferase enzyme against proteolytic degradation (e.g., toward trypsin), thereby increasing its half-life with subsequent enhancement of total cellular luminescence that eventually mimicked PXR-driven luciferase induction. These data show that particular compounds can strikingly interfere with firefly luciferase and once more illustrate the importance of careful interpretation of data obtained from luciferase-based assays. 
650 4 |a Bortezomib 
650 4 |a Carfilzomib 
650 4 |a Firefly luciferase 
650 4 |a Inhibition 
650 4 |a Ixazomib 
650 4 |a Reporter gene assay 
700 1 |a Clemens, Jannick  |d 1988-  |e VerfasserIn  |0 (DE-588)1099995574  |0 (DE-627)858946041  |0 (DE-576)469452935  |4 aut 
700 1 |a Theile, Dirk  |e VerfasserIn  |0 (DE-588)1019114428  |0 (DE-627)684195658  |0 (DE-576)356996360  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
773 0 8 |i Enthalten in  |t Analytical biochemistry  |d San Diego, Calif. : Elsevier, 1960  |g 509(2016), Supplement C, Seite 124-129  |h Online-Ressource  |w (DE-627)25378641X  |w (DE-600)1461105-3  |w (DE-576)103372997  |x 1096-0309  |7 nnas  |a Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays 
773 1 8 |g volume:509  |g year:2016  |g number:Supplement C  |g pages:124-129  |g extent:6  |a Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays 
856 4 0 |u http://dx.doi.org/10.1016/j.ab.2016.06.015  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0003269716301427  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171222 
993 |a Article 
994 |a 2016 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 1019114428  |a Theile, Dirk  |m 1019114428:Theile, Dirk  |d 910000  |d 910100  |e 910000PT1019114428  |e 910100PT1019114428  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1099995574  |a Clemens, Jannick  |m 1099995574:Clemens, Jannick  |d 910000  |d 910100  |e 910000PC1099995574  |e 910100PC1099995574  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1050230825  |a Becker, Jonas Philipp  |m 1050230825:Becker, Jonas Philipp  |d 50000  |e 50000PB1050230825  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1566741424  |e 2991458224 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 22.12.2017"],"recId":"1566741424","person":[{"role":"aut","family":"Becker","given":"Jonas Philipp","display":"Becker, Jonas Philipp"},{"family":"Clemens","role":"aut","given":"Jannick","display":"Clemens, Jannick"},{"role":"aut","family":"Theile","given":"Dirk","display":"Theile, Dirk"},{"display":"Weiß, Johanna","given":"Johanna","role":"aut","family":"Weiß"}],"name":{"displayForm":["Jonas Philipp Becker, Jannick Robert Clemens, Dirk Theile, Johanna Weiss"]},"language":["eng"],"origin":[{"dateIssuedDisp":"17 June 2016","dateIssuedKey":"2016"}],"relHost":[{"disp":"Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assaysAnalytical biochemistry","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1960 - 443.2013; Vol. 444.2014 -"],"note":["Gesehen am 09.11.2020"],"language":["eng"],"part":{"text":"509(2016), Supplement C, Seite 124-129","issue":"Supplement C","pages":"124-129","extent":"6","year":"2016","volume":"509"},"origin":[{"dateIssuedDisp":"1960-","publisher":"Elsevier ; Academic Press ; Academic Press, Elsevier Science","publisherPlace":"San Diego, Calif. ; New York, NY [u.a.] ; San Diego, Calif.","dateIssuedKey":"1960"}],"title":[{"title":"Analytical biochemistry","subtitle":"methods in the biological sciences","title_sort":"Analytical biochemistry"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["25378641X"],"issn":["1096-0309"],"zdb":["1461105-3"]},"recId":"25378641X"}],"physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1016/j.ab.2016.06.015"],"eki":["1566741424"]},"title":[{"title":"Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays","title_sort":"Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BECKERJONABORTEZOMIB1720